American Journal of Cardiology
Volume 104, Issue 6 , Pages 840-845 , 15 September 2009

Effects of the Cyclooxygenase Inhibiting Nitric Oxide Donator Naproxcinod Versus Naproxen on Systemic Blood Pressure in Patients With Osteoarthritis

  • William B. White, MD

      Affiliations

    • Pat and Jim Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, Connecticut
    • Corresponding Author InformationCorresponding author: Tel: 860-679-2104; fax: 860-679-1250
  • ,
  • Thomas J. Schnitzer, MD, PhD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
  • ,
  • Rosanna Fleming, MS

      Affiliations

    • Clinical Development & Medical Affairs, NicOx S.A., Sophia-Antipolis, France
    • NicOx, Inc., Warren, New Jersey
  • ,
  • Brigitte Duquesroix, MD

      Affiliations

    • Clinical Development & Medical Affairs, NicOx S.A., Sophia-Antipolis, France
    • NicOx, Inc., Warren, New Jersey
  • ,
  • Maarten Beekman, MD

      Affiliations

    • Clinical Development & Medical Affairs, NicOx S.A., Sophia-Antipolis, France
    • NicOx, Inc., Warren, New Jersey

Received 4 April 2009 ,Revised 5 May 2009 ,Accepted 5 May 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0002-9149(09)01049-2

doi: 10.1016/j.amjcard.2009.05.014

American Journal of Cardiology
Volume 104, Issue 6 , Pages 840-845 , 15 September 2009